Compared with the patients in the non-NOAF group, those in the NOAF group were older and more likely to have a higher FAR; blood cell counts for WBCs and neutrophils; serum levels of high-sensitivity C-reactive protein, FIB, Scr and BNP; cardiac troponin I; LA; and Killip class, as well as a history of diabetes or stroke (p<0.05). The gene discussed is NPPB; the disease is stroke disorder.